Rigid viral lipid membrane domains

Rigid viral lipid membrane domains, often referred to as viral lipid rafts, are highly organized, cholesterol- and sphingolipid-rich microdomains within the lipid envelope of many viruses, including HIV, Influenza, and SARS-CoV-2. These domains serve as critical platforms for viral entry, assembly, and budding by concentrating viral glycoproteins and facilitating the membrane fusion process required for infection (Rawat et al., 2003, Separation and Purification Technology). Unlike host cell membranes, viral envelopes lack active repair mechanisms, making these rigid domains a vulnerable target for broad-spectrum antiviral therapy. Drugs targeting these domains, such as the aryl methyldiene rhodanine derivative LJ001, exploit the biophysical differences between viral and cellular membranes to selectively inhibit viral fusion without significantly damaging host cells (Wolf et al., 2010, PNAS). By disrupting the fluidity or structural integrity of these domains, therapeutic agents can effectively neutralize a wide range of enveloped viruses regardless of their specific protein mutations.

Other names

Viral lipid raftsOrdered viral lipid domainsViral envelope lipidsCholesterol-rich viral membrane microdomains

Drugs targeting these domains typically act by disrupting the biophysical properties of the viral envelope, such as fluidity and curvature, or by depleting essential components like cholesterol. For instance, LJ001 intercalates into the viral membrane and, upon light activation or through oxidative stress, induces covalent changes in unsaturated phospholipids, increasing membrane rigidity and preventing the conformational changes required for membrane fusion with the host cell (Vigant et al., 2013, PLoS Pathogens). Other agents like cyclodextrins physically extract cholesterol, leading to the collapse of these ordered domains and subsequent loss of infectivity (Liao et al., 2003, AIDS Research and Human Retroviruses).